Therapy for Severe Psoriasis

Therapy for Severe Psoriasis is a comprehensive guide addressing the management of the most challenging cases of psoriasis. Written by leading dermatology experts, the book covers the full spectrum of modern treatment strategies, from traditional systemic therapies to the latest biologics and oral agents, with an emphasis on evidence-based approaches. It also provides guidance for clinicians new to managing severe psoriasis, helping them navigate complex subtypes and therapeutic decision-making.

Key Features

• In-depth exploration of both conventional and advanced therapies, including UVB therapy, methotrexate, acitretin, cyclosporine, apremilast, and multiple biologics (etanercept, infliximab, adalimumab, ustekinumab, secukinumab, ixekizumab).
• Discussion of newly approved drug therapies and FDA-approved biosimilars, highlighting cutting-edge options in psoriasis management.
• Focus on combination treatment strategies for patients who do not respond to single therapies.
• Evidence-based guidance for difficult-to-treat subtypes, emphasizing individualized patient care.
• Overview chapter designed to help clinicians understand the nuances of severe psoriasis and integrate therapies effectively.

Product Details

• Publisher: Elsevier; 1 Har/Psc edition (December 14, 2016)
• Language: English
• ISBN-10: 032344797X
• ISBN-13: 978-0323447973